Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 28, 2020 Off

IDT Offers Preferred Pricing and Early Access to Complete Portfolio of Coronavirus Research Tools

By BusinessWire

Complete qPCR panel of the CDC-published sequences for coronavirus detection in addition to preferred pricing on gBlocks fragments and synthetic…

January 28, 2020 Off

Vascular Therapies Completes Upsized $17.3 Million Private Financing

By BusinessWire

– Company funded through 2020. Topline Phase 3 results for Sirogen expected to be announced in Q2 2020 – CRESSKILL,…

January 28, 2020 Off

US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell

By BusinessWire

MONTPELLIER, France–(BUSINESS WIRE)–Euronext: MEDCL “Clinical development will become a significant part of MedinCell’s expenses and will define the time to…

January 28, 2020 Off

US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell

By BusinessWire

MONTPELLIER, France–(BUSINESS WIRE)–Euronext: MEDCL “Clinical development will become a significant part of MedinCell’s expenses and will define the time to…

January 28, 2020 Off

Dr. Ami Claxton, MS, PhD Joins STATinMED Team

By BusinessWire

Bringing extensive experience to expand service offerings PLANO, Texas–(BUSINESS WIRE)–#HEOR–STATinMED Research, a leading health economics and outcomes research (HEOR) company,…

January 28, 2020 Off

Dr. Ami Claxton, MS, PhD Joins STATinMED Team

By BusinessWire

Bringing extensive experience to expand service offerings PLANO, Texas–(BUSINESS WIRE)–#HEOR–STATinMED Research, a leading health economics and outcomes research (HEOR) company,…

January 28, 2020 Off

Merck Announces Second-Quarter 2020 Dividend

By BusinessWire

KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board…

January 28, 2020 Off

Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications

By BusinessWire

BOSTON–(BUSINESS WIRE)–#CEO—Invicro LLC, a Konica Minolta company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients…

January 28, 2020 Off

Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications

By BusinessWire

BOSTON–(BUSINESS WIRE)–#CEO—Invicro LLC, a Konica Minolta company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients…

January 28, 2020 Off

Precision Medicine Leaps Ahead with Data Science: Bio-IT World 2020 to Highlight Data-Driven Approaches to Discovery

By BusinessWire

3,200 Life Science and IT Leaders to Unite for Conference and Expo, April 21-23 in Boston BOSTON–(BUSINESS WIRE)–#AI—Bio-IT World 2020,…

Posts pagination

Previous 1 … 5,170 5,171 5,172 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine